Tildren

Managing the clinical signs of navicular syndrome in horses can present a challenge. Tildren® (tiludronate disodium) offers a proven option for veterinarians and horse owners. Indicated for the control of clinical signs associated with navicular syndrome in horses four years and older, Tildren restores balance to the process of bone remodeling.
 
Following IV infusion, Tildren travels through the blood stream and binds to the mineral matrix of the bone. The acidity of the remodeling environment causes the release of Tildren from the bone matrix to the resorption space. This leads to improved bone remodeling, decreased mineral loss and alleviation of pain induced by abnormal osteolysis.